PFM Health Sciences’s ARK Innovation ETF ARKK Stock Holding History

PFM Health Sciences’s Portfolio ARKK Stock Details ARKK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-242,260	Closed	-$12.1M	–	80
2024 Q1	$12.1M	Buy	+242,260	New	+$11.8M	0.57%	50

Other funds holding ARKK

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

PFM Health Sciences's ARKK Position: Q2 2024 in Review

PFM Health Sciences sold out of ARK Innovation ETF (ARKK) in Q2 2024, closing a stake of 242,260 shares — an estimated $12.1M sold.

PFM Health Sciences first reported a position in ARKK in Q1 2024 and held it in 1 quarter. The position peaked at $12.1M in Q1 2024. 590 funds tracked by Wall St. Rank hold ARKK as of Q2 2024.

PFM Health Sciences reported no remaining ARK Innovation ETF position as of Q2 2024 after selling out during the quarter.
PFM Health Sciences sold 242,260 ARK Innovation ETF shares in Q2 2024, an estimated $12.1M.
PFM Health Sciences first reported a position in ARK Innovation ETF in Q1 2024 and held it in 1 quarter.
PFM Health Sciences's ARK Innovation ETF position peaked at $12.1M in Q1 2024.
590 funds tracked by Wall St. Rank held ARK Innovation ETF as of Q2 2024.

Based on PFM Health Sciences's 13F filing for Q2 2024, filed 14 Aug 2024.